Literature DB >> 22256352

The short life of a race drug.

Sheldon Krimsky1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22256352     DOI： 10.1016/s0140-6736(12)60052-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Communication Strategies Must Be Tailored to a Medication's Targeted Population: Lessons from the Case of BiDil.

Authors:  Chamika Hawkins-Taylor; Angeline M Carlson
Journal:  Am Health Drug Benefits       Date:  2013-09

2.  Moving Beyond Self-Reported Race in Our Understanding of Cardiovascular Medicine.

Authors:  Nancy Luo
Journal:  J Am Heart Assoc       Date:  2022-06-20       Impact factor: 6.106

3.  Advancing genomic research and reducing health disparities: what can nurse scholars do?

Authors:  Cheedy Jaja; Robert Gibson; Shirley Quarles
Journal:  J Nurs Scholarsh       Date:  2013-03-01       Impact factor: 3.176

4.  BiDil in the Clinic: An Interdisciplinary Investigation of Physicians' Prescription Patterns of a Race-Based Therapy.

Authors:  Koffi N Maglo; Jack Rubinstein; Bin Huang; Richard F Ittenbach
Journal:  AJOB Empir Bioeth       Date:  2014-10-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.